$0.00040
At close: May 20, 9:48 AM EDT
Comments
Loading...
Premier Biomedical Analyst Ratings and Price Targets | OTC:BIEI | Benzinga
Premier Biomedical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Premier Biomedical Corp from these most-recent analyst ratings.
Analyst Ratings for Premier Biomedical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Premier Biomedical (BIEI) stock?
There is no price target for Premier Biomedical
What is the most recent analyst rating for Premier Biomedical (BIEI)?
There is no analyst for Premier Biomedical
When was the last upgrade for Premier Biomedical (BIEI)?
There is no last upgrade for Premier Biomedical
When was the last downgrade for Premier Biomedical (BIEI)?
There is no last downgrade for Premier Biomedical.
When is the next analyst rating going to be posted or updated for Premier Biomedical (BIEI)?
There is no next analyst rating for Premier Biomedical.
Is the Analyst Rating Premier Biomedical (BIEI) correct?
There is no next analyst rating for Premier Biomedical.
Browse analyst ratings and price targets on all stocks.
